JAZZ vs SPCE · P/E 1988, rev $2.28B vs rev $361.0K
Jazz Pharmaceuticals PLC (JAZZ) versus Virgin Galactic Holdings Inc (SPCE) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Virgin Galactic Holdings Inc (SPCE) is a aerospace & defense company listed on NYSE.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported SPCE revenue for 2026-06-30 was $361.0K. Net income was -$120.6M. Revenue was up 59.0% from 2026-03-31 to 2026-06-30. SPCE currently screens at market cap $388.0M.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. SPCE currently screens at market cap $388.0M.
Not investment advice. Open the JAZZ and SPCE stock pages for the full models.
Not investment advice.